Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III BRISK-PS study. (Q45980006)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III BRISK-PS study. |
scientific article |
Statements
Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III BRISK-PS study (English)
Jean-Luc Raoul
Eveline Boucher
Won-Young Tak
Charissa Chang
Yoon-Koo Kang
Eric Assenat
Ho-Yeong Lim
Laetitia Fartoux
Deng-Yn Lin
Ronnie T Poon
Morris Sherman
Jean-Frédéric Blanc
Richard S Finn
Yee Chao
Rana Ezzeddine
David Liu
Ian Walters